-
Generalizability of Patient Preference Study Results: A Weight and Test Approach
Sep 9, 2025, 16:22 PM -
Care Pathways Before and After Initial Diagnosis and Geographical Disparities Among Patients With Obstructive Hypertrophic Cardiomyopathy in France: A Retrospective Claims Analysis
Sep 9, 2025, 16:22 PM -
Comparative Epidemiological Burden of Osteoarthritis in Eastern Central and Western Europe Based on the Global Burden of Disease Study 2021
Sep 9, 2025, 16:22 PM -
CDF or CDFoe: How Has the Cancer Drugs Fund Impacted Access to Atezolizumab for Patients With Non-Small Cell Lung Cancer in the Adjuvant Setting?
Sep 9, 2025, 16:22 PM -
Embedding Patient Experience Data (PED) in EU Joint Clinical Assessments: Strategic Imperatives and Evidence Practices
Sep 9, 2025, 16:22 PM -
Effectiveness and Safety of Radiofrequency Nucleolysis for Chronic or Acute Low Back Pain
Sep 9, 2025, 16:22 PM -
Quantifying the Societal Burden of Acanthamoeba Keratitis: Results From a Patient Survey
Sep 9, 2025, 16:22 PM -
Occurrence of Exacerbations and Mortality in High-Risk Chronic Obstructive Pulmonary Disease Patients While on Treatment With Dual or Triple Inhaled Therapy: Results From the SIRIUS Observational Study in the US
Sep 9, 2025, 16:22 PM -
Economic Evaluation of the Adoption of Peritoneal Dialysis for Newly Diagnosed Hemodialysis Ineligible Pediatric End-Stage Kidney Disease Patients in Egypt
Sep 9, 2025, 16:22 PM -
Extending Survival in Glioblastoma: Real-World Evidence of Post-Progression Benefit From Tumor-Treating Fields Therapy
Sep 9, 2025, 16:22 PM -
Disproportionality Analysis Of Vedolizumab to Identify a Putative Signal Using Real-World Postmarketing Surveillance Data Reported in the FAERS Database
Sep 9, 2025, 16:22 PM -
Design Operating Characteristics in a Noninterventional Study Framework
Sep 9, 2025, 16:22 PM -
Characteristics of Real-World Data Landscape in Italy: A Scoping Review
Sep 9, 2025, 16:22 PM -
Real-World Evidence Study on PD-L1 Testing and Use of Immuno-Oncology (IO) Treatments Among Cancer Patients in the Helsinki and Uusimaa (HUS) Region, Finland
Sep 9, 2025, 16:22 PM -
Perspectives of Patients and Healthcare Providers on a Shared Decision-Making Dashboard in Rheumatoid Arthritis Care
Sep 9, 2025, 16:22 PM -
The Growing Importance of Reserve Antibiotics in Organ Transplant Care and the Role of Timely Appropriate Antibiotic Treatment to Preserve the Benefits of Prior Health Investments
Sep 9, 2025, 16:22 PM -
Feasibility Assessment of an Indirect Treatment Comparison of Seladelpar vs. Elafibranor in Patients With Primary Biliary Cholangitis
Sep 9, 2025, 16:22 PM -
Evaluating High-Cost Gene Therapies for Noncancer Conditions: Insights From NICE's Standard Appraisal Process
Sep 9, 2025, 16:22 PM -
Exploring Off-Label Drug Coding Trends in French Hospitals: A Descriptive and Stratified Analysis 2020-2024
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of RSVpreF Vaccine for RSV Prevention in Older Adults Under Situation of the National Vaccination Program in Taiwan: A Study on Economic and Clinical Advantages
Sep 9, 2025, 16:22 PM
